Digital Inclusion and Access to Care by Telemedicine

About the Speakers

John Scott, MD, MSc, FIDSA, is a Professor of Medicine (Division of Allergy and Infectious Diseases) and Chief Digital Health Officer at UW Medicine.  He graduated from Stanford University with a degree in Human Biology, attended Georgetown University School of Medicine cum laude, completed a residency in Internal Medicine at Stanford University Hospitals, and then obtained sub-specialty training in Infectious Diseases at the University of Washington.  He joined the University of Washington faculty in 2005.

In 2009, he launched Project ECHO (Extension for Community Health Outcomes) in Washington State, the first place to replicate the ECHO model outside of New Mexico.  This innovative telehealth program helps clinicians serving in rural and underserved areas with the evaluation and treatment of common, complex, chronic diseases.  In 2015, he won the Warren Reid Award for excellence in health care for the state of Washington, in recognition of his telehealth work.  He chairs the Washington State Telehealth Collaborative and served on the Telehealth committee for the Infectious Disease Society of America. The Washington State Medical Association recognized him with the Grassroots Advocate Award in 2020 for his work in advocating for policy changes for telemedicine at the state and federal level.

In his role as Chief Digital Health Officer, he is focused on Virtual Care Delivery and developing a robust Digital Front Door to bring together UW Medicine’s existing technologies, apps, and other digital services into a simple, single sign-on platform.

Cindy Jacobs, RN, JD, brings over 30 years of combined legal and health care experience to her role as a regulatory consultant with the ITHS Technology Development Center. As a registered nurse before attending law school, she focused on the clinical specialty of neonatology, including 3 years in an advanced practice role. As an attorney, she has represented and advised health care clients regarding a variety of issues, including telemedicine and other health care technologies, FDA law, HIPAA, reimbursement and related compliance, health care contracting, risk management/professional liability, scope of practice/licensing, informed consent, and product liability. Cindy’s UW roles have included Assistant Attorney General in the UW Attorney General’s Office, Director of Clinical Risk Management for UW Medical Center, and Director of Clinical Projects for the UW School of Medicine. She also continues to teach FDA Law at UW School of Law, which she has done since 2010, along with periodic law student seminars on telemedicine and healthcare clinical compliance. She is a member of the ITHS Drug and Device Advisory Committee.

Margaret Rosenfeld, MD, MPH, is attending physician at Seattle Children’s Hospital, Professor in the Department of Pediatrics at the University of Washington School of Medicine and Adjunct Professor in the Department of Epidemiology at the University of Washington School of Public Health. She is Associate Vice Chair for Clinical Research in the Department of Pediatrics and Co-Director of the Center for Clinical and Translational Research at the Seattle Children’s Research Institute.

Her clinical interests focus on the diagnosis and management of respiratory illnesses in children of all ages, working closely with families. She serves as CF consultant to the Washington State Newborn Screening Program. Her research program focuses on NIH and foundation-sponsored multicenter observational and interventional studies in pediatric chronic lung diseases, including cystic fibrosis and primary ciliary dyskinesia. She also conducts research on mobile health tools for respiratory diseases including home spirometry.

Charlie Gregor, MPH, is the manager of the Hub Liaison Team and the Network Capacity Component of the ITHS. Charlie has held positions in non-profit, hospital, non-academic and academic research settings, bringing significant experience in business, project and clinical trial management. Following a decade in business administration and completing a master’s in public health from the University of Minnesota, where he focused on infectious disease studies and epidemiology, he subsequently progressed through research related positions. He developed a research site assessment program, expanding US FDA regulated HIV research to Southern and Eastern Africa, sat on the Steering Committee for the Rapid Acceleration of Diagnostics in Underserved Populations (RADx-UP), consortium, was the operations lead for FDA regulated domestic and international (phase 1-3) drug trials, established the first Trial Innovation Network (TIN) Hub Liaison Team at the University of Washington and has been disseminated over 15 times. Currently, Charlie is the operations lead for the Andy Hill Cancer Research Endowment funded project (RADIANT) to improve the diversity and inclusion of enrolled participates in oncology research within community based research settings and supports the UW Medicine Office of Healthcare Equity implement Washington HB 1745, requiring measures to increase the diversity of enrolled participants in drug and device trials.